IL17A and breast cancer: The results of GSVA showed that MTFP1 showed a negative correlation to most immune cells and upregulated IL-17 signaling pathways, calcium signaling pathways, breast cancer, negative regulation of epithelial cell apoptotic process, negative regulation of endothelial cell apoptotic process, and fibrinolysis, indicating that MTFP1 promotes tumor growth and progression.